All Comments by John Trojanowski
- Drug evaluation: (R)-flurbiprofen--an enantiomer of flurbiprofen for the treatment of Alzheimer's disease.
- Chronic traumatic encephalopathy in a national football league player: part II.
- Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.
- Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia.
- CSF Biomarkers—Maybe You Can See the Forest for the Trees
- Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
- 100 years and counting: prospects for defeating Alzheimer's disease.
- A century of Alzheimer's disease.
- Chronic lithium administration to FTDP-17 tau and GSK-3beta overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert.
- A peptide zipcode sufficient for anterograde transport within amyloid precursor protein.
- Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles.
- Double Paper Alert—A Function for BACE, a Basis for Amyloid
- HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin.
- Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.
- Dangerous Liaisons—Tau and Aβ, Together at Last?